• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Studio
  • Genomics
  • Solutions
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • Newsroom
    • Careers
Get started
Sign in
Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

Q&A: Exploring with The Wall Street Journal Truveta’s EHR data on speech delays

by Truveta staff | May 19, 2023 | Technology

The Wall Street Journal recently published a story, If Your Toddler Isn’t Talking Yet, the Pandemic Might Be to Blame, based on a new pre-print published by Truveta Research on MedRxiv, which investigated speech delays in children under age 5 as an unexpected outcome...
Truveta Research presents at the 150th Annual APHA

Truveta Research presents at the 150th Annual APHA

by Truveta staff | Nov 18, 2022 | News, Research

Last week, two members of Truveta Research — Dr. Charlotte Baker, DrPH, MPH, CPH, and Dr. Peter Smits, PhD — attended the 150th Annual Meeting of the American Public Health Association (APHA) in Boston. Dr. Peter Smits presented on Truveta Research’s...
Disparities in COVID-19 hospitalizations: From insights to publication

Disparities in COVID-19 hospitalizations: From insights to publication

by Truveta Research | Nov 2, 2022 | Research, Research Insights

UPDATE 1/11/2023: The analysis in this blog has been published as a part of a peer-reviewed paper in Frontiers in Public Health: Racial inequality in COVID treatment and in-hospital length of stay in the US over time. Many researchers have goals to conduct novel...
Digging deeper: Understanding more about patient subgroups with peripheral artery disease

Digging deeper: Understanding more about patient subgroups with peripheral artery disease

by Truveta Research | Oct 4, 2022 | Research, Research Insights

Peripheral Artery Disease (PAD) is a common disease that causes the arteries in the extremities to narrow. Recently, as part of PAD Awareness Month, we investigated disparities in the frequency of common procedures used to treat PAD, known as endovascular (or...
Peripheral artery disease treatment and outcomes: Disparities in frequency of revascularization procedures and incidence of adverse outcomes

Peripheral artery disease treatment and outcomes: Disparities in frequency of revascularization procedures and incidence of adverse outcomes

by Truveta Research | Sep 27, 2022 | Research, Research Insights

Peripheral artery disease (PAD) is a common disease that causes narrowing of the arteries in the extremities. The lifetime risk for Americans varies between 19-30% [1]. Many studies have shown that PAD disproportionately affects both Black or African American...
« Older Entries

Share this


Recent posts

  • How Truveta benchmarks AI model quality for clinical concept extraction
  • Truveta Data analysis shows improved outcomes with Impella support in high-risk heart procedures
  • Evaluating recent trends in early measles vaccinations in Texas

Follow Truveta


Sign up for our newsletter

Our website uses cookies to ensure you have the best experience.AcceptPrivacy notice